ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1

Historical Portfolio Holders from Q4 2021 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Debt / NOTE 4.000%11/1
Principal, excl. options Q2 2024
152M
Holdings value Q2 2024
$188M
Value change Q2 2024
+$195K
Grand Portfolio weight change Q2 2024
+0%
Number of holders
18
Number of buys Q2 2024
0
Number of sells Q2 2024
0
Average buys Q2 2024 %
0
Average sells Q2 2024 %
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q2 $152M $188M +$195K $0.92 18
2024 Q1 $168M $172M -$14.9B $0.83 17
2023 Q4 $210M $123M +$10.8M $0.58 18
2023 Q3 $192M $111M -$4.4M $0.52 17
2023 Q2 $198M $109M -$6.11M $0.50 18
2023 Q1 $237M $104M -$397K $0.40 20
2022 Q4 $235M $133M +$4.39M $0.55 20
2022 Q3 $215M $128M -$42.8K $0.56 19
2022 Q2 $215M $126M +$772K $0.54 19
2022 Q1 $212M $119M +$5.21M $0.52 20
2021 Q4 $200M $116M +$116M $0.53 17